Harvard Apparatus Regenerative Technology appoints StellarS Capital CEO Mao Zhang to board

Harvard Apparatus Regenerative Technology, Inc.

Mao Zhang, Founder & CEO of multi-billion-dollar alternative asset manager StellarS Capital, appointed as independent Class I director effective Aug 26, 2024.
Mr. Zhang will receive $25,000 stock option grant vesting quarterly over one year; standard non-employee director compensation ($20k cash + $25k options annually).
Mr. Zhang has over 15 years financial markets experience; previously led Magnetar Capital's Asian business.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mao Zhang

Class I Director

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2024-08-26
Filed: August 27, 2024, 7:59 PM ET

On August 26, 2024, Mao Zhang, the Founder and Chief Executive Officer of Stellars Capital, joined the Board of Directors (the “Board”) of the Company as a Class I director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mao Zhang was appointed as Class I Director at Harvard Apparatus Regenerative Technology, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

On August 26, 2024, Mao Zhang, the Founder and Chief Executive Officer of Stellars Capital, joined the Board of Directors (the “Board”) of the Company as a Class I director.

View on SEC.gov

Harvard Apparatus Regenerative Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-034014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.